Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
01/2011
01/12/2011CN101942415A Hybridoma cell strain and anti-hydrochloric acid clenbuterol monoclonal antibody prepared from hybridoma cell strain
01/12/2011CN101942414A Hybridoma cell line and chloramphenicol-resistant monoclonal antibody produced by same
01/12/2011CN101942413A Birth defect cell bank and construction method thereof
01/12/2011CN101942412A Large-scale separation method of rice immature embryos
01/12/2011CN101942026A Long-acting interferon fusion protein and application thereof
01/12/2011CN101942025A Heparanase III fusion protein and coding gene and expression method thereof
01/12/2011CN101942024A Heparanase II fusion protein and coding gene and expression method thereof
01/12/2011CN101942019A Factor VII or VIIa polypeptide variants
01/12/2011CN101940781A New method for inhibiting synthesis of liver fat and preventing and treating fatty liver
01/12/2011CN101940780A Zinc finger protein ZBTB20 in chondrocyte-specific knockout mouse model and application thereof
01/12/2011CN101940594A Preparation for treating ischemic cardiovascular diseases and preparation method thereof
01/12/2011CN101940593A Preparation for treating ischemic diseases caused by peripheral atherosclerosis and preparation method thereof
01/12/2011CN101940592A Preparation for treating ischemic cerebrovascular disease and preparation method thereof
01/12/2011CN101940591A Preparation for promoting revascularization or angiogenesis and preparation method thereof
01/12/2011CN101940590A Preparation for promoting wound healing and preparation method thereof
01/12/2011CN101940589A Medicament for preventing and treating neurologic damage and related diseases thereof
01/12/2011CN101940189A Transgenic trasnchromosomal rodents for making human antibodies
01/12/2011CN101638640B Glucose-6-phosphoric acid dehydrogenase and nucleotide sequence, recombinant vector, recombinant host cell and kit thereof
01/12/2011CN101565690B Enrofloxacin monoclonal antibody and application
01/12/2011CN101532015B Anther tapetum and pollen specific efficient promoter as well as application thereof
01/12/2011CN101531713B Bt protein Cry56Aal as well as encoding gene thereof and application thereof
01/12/2011CN101531711B Bt protein Cry52Bal as well as encoding gene thereof and application thereof
01/12/2011CN101503675B Oophoroma multidrug resistance cell strain established by etoposide induction
01/12/2011CN101503673B Cervical cancer multidrug resistance cell strain established by etoposide induction
01/12/2011CN101270162B Antihuman SCGN monoclone antibody, preparation, application and hybrid tumor cell strain
01/12/2011CN101235085B Monoclonal antibody of membrane protein E for resisting West Nile virus and application thereof
01/12/2011CN101213941B Fast replication and in-vitro conservation method for dendrobium
01/12/2011CN101138317B Tissue inner carrying bacterium explant disinfection processing method
01/12/2011CN101112172B Physic nut polyploid inducement method under the isolated culture condition
01/12/2011CN101084305B Pancreatic island separation method
01/12/2011CN101066041B Aseptic seeding and tissue culture process of cymbidium lianpan
01/11/2011US7868233 Maize variety PHH7E
01/11/2011US7868228 DNA constructs for their expression in host cells, seed, oil and meal when the host cells comprise a plant; producing docosahexaenoic acid and eicosapentaenoic acid from plants
01/11/2011US7868227 improved ability to enzymatically degrade lignocellulosic feedstocks; fermentation
01/11/2011US7868226 regulate the proanthocynanidin biosynthetic pathway and proanthocynanidin biosynthesis in a plant; genetic engineering
01/11/2011US7868158 Modulation of cytokine signaling regulators and applications for immunotherapy
01/11/2011US7868156 cultivating a transgenic plant containing a nucleotide sequences coding polypeptide, proteins and other products of interest; controlling expression of nucleic acid sequences; product is produced in seed of the plant; increase the oleic acid content of rapeseed oil
01/11/2011US7868155 Promoter, promoter control elements, and combinations, and uses thereof
01/11/2011US7868154 Promoter to IL-18BP, its preparation and use
01/11/2011US7868152 Capable of detecting and isolating polypeptides that are tyrosine-sulfated; used to discriminate between the non-sulfated and sulfated forms of the antibodies; useful in a wide variety of immunological protein assays and isolation procedures
01/11/2011US7868150 Nucleic acids encoding T2R taste receptors
01/11/2011US7868142 Protein, method for immobilizing protein, structure, biosensor, nucleic acid, vector and kit for detecting target substance
01/11/2011US7867973 comprises follistatin domain I; free of an amino acid sequence represented by formula (I): Cys-(X1)a-Cys-(X2)b-Cys-(X3)c-Cys-(X4)d-Cys-(X5)e-Cys-(X6)f-Cys-(X7)g-Cys-(X8)h-Cys-(X9)i-Cys [x=natural amino acids]; inhibiting GDF-8 activity without inhibiting activin activity
01/11/2011US7867752 having a dynamically controlled environment for incubating cells; for use in the propagation of cells such that an array of single cells, or a functional ensemble, can be grown and individually analyzed
01/11/2011US7867743 phytases derived from Citrobacter braakii, belong to the acid histidine phosphatase family, are acid-stable, and expectedly of a high specific activity; animal feed
01/11/2011US7867733 Method for producing factor G derived from horseshoe crab
01/11/2011US7867725 Bone matrix glycoprotein specific immunoglobulin for use in diagnosing renal injury, cancer, cardiovascular and inflammatory disorders
01/11/2011US7867721 detects mechanical stimuli and convert them into electrical signals; used to diagnose and treat Meniere's disease, sensorineural deafness, blood pressure disorders and cancer
01/11/2011US7867519 Method for the acceleration or deceleration of angiogenesis using fibrin matrix formed from increased or decreased HMW/LMW fibrinogen ratio
01/11/2011US7867498 comprise at least five CD4+ T cell epitopes, for conjugation to capsular polysaccharides; for use in treatment and prevention of plasmodial infection; genetic vaccines; for immunization
01/11/2011US7867488 Use of dendritic cells (DCs) expressing interleukin 12 (IL-12)
01/11/2011CA2421212C Manipulation of plant senescence using an myb gene promoter and cytokinin biosynthesis genes
01/11/2011CA2380767C Cell growth substrate
01/11/2011CA2377479C Compositions and methods for preventing transepithelial transmission of hiv
01/11/2011CA2310562C Novel pectate lyases
01/06/2011WO2011002959A1 Method of producing erythrocytes without feeder cells
01/06/2011WO2011002955A2 Methods for making embryonic cells, embryos, and animals sensitized to stress
01/06/2011WO2011002926A2 Isolated adult cells, artificial organs,rehabilitated organs, research rools, organ encasements, organ perfusion systems, and methods for preparing and utilizing the same
01/06/2011WO2011002894A1 High-throughput culture and transfer device and method
01/06/2011WO2011002727A1 Methods of producing humanized non-human mammals
01/06/2011WO2011001965A1 Method for designing small rna duplex and hairpin rna
01/06/2011WO2011001936A1 Blood component separation system and separation material
01/06/2011WO2011001885A1 Bioassay method for antibody against thyroid-stimulating hormone receptor, measurement kit for the antibody, and novel genetically modified cell for use in the bioassay method or the measurement kit
01/06/2011WO2011001882A1 Flagellin mutant capable of effectively inducing protective capability on infection by pseudomonas aeruginosa
01/06/2011WO2011001722A1 Maltotriocil transferase, process for production thereof, and use thereof
01/06/2011WO2011001116A1 Unshrunken tissue equivalent, skin equivalent comprising such an unshrunken tissue equivalent, and methods for producing such an unshrunken tissue equivalent and such a skin equivalent
01/06/2011WO2011000860A2 Targets for retrovirus associated diseases
01/06/2011WO2011000116A1 Use of steroidal compounds for the conversion of normal b lymphocytes into immunoglobulin-secreting plasma cells
01/06/2011WO2010129917A3 Anti-cd100 antibodies and methods for using the same
01/06/2011WO2010104617A3 Methods to induce a state of immune tolerance
01/06/2011WO2010101921A3 Tumor-selective e1a and e1b mutants
01/06/2011WO2010096594A3 Method for identifying a subpopulation of mammalian cells with distinctive ribosome translation profiles
01/06/2011WO2010096588A3 Cell culture media containing combinations of proteins
01/06/2011US20110004965 Compositions and methods for modulation of plant cell division
01/06/2011US20110004964 Insecticidal proteins derived from bacillus thuringiensis
01/06/2011US20110004963 Plants Having Increased Yield-Related Traits And A Method For Making The Same
01/06/2011US20110004959 Down-regulation and silencing of allergen genes in transgenic peanut seeds
01/06/2011US20110004958 Compositions for silencing the expression of gibberellin 2-oxidase and uses thereof
01/06/2011US20110004957 Genetically modified reduced-browning fruit-producing plant and produced fruit thereof, and method of obtaining such
01/06/2011US20110004955 Transgenic plants with enhanced agronomic traits
01/06/2011US20110004954 Inbred Cucurbita Pepo Pumpkin HSPMR7B1 Having a Mutant Allele For Powdery Mildew Resistance
01/06/2011US20110004952 Method for the separation of cells
01/06/2011US20110004951 Methods and compositions for identifying compounds that inhibit hiv-1 subunit-specific reverse transcriptase
01/06/2011US20110004949 Immunoglobulin 1
01/06/2011US20110004948 Immunoglobulin 2
01/06/2011US20110004947 Compositions and methods for osteogenic gene therapy
01/06/2011US20110004304 Culturing retinal cells and tissues
01/06/2011US20110004052 Cryopreserved selected sperm cell sample
01/06/2011US20110004051 Composition for separating spermatozoa from a semen sample
01/06/2011US20110003973 Antibodies to zalpha11 cytokine receptors
01/06/2011US20110003882 RNAi Modulation of AHA and Therapeutic Uses Thereof
01/06/2011US20110003881 Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression
01/06/2011US20110003877 SMAC Mimetic
01/06/2011US20110003851 Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors
01/06/2011US20110003824 Caspase Inhibitors and Uses Thereof
01/06/2011US20110003814 Pyrimidines useful as modulators of voltage-gated ion channels
01/06/2011US20110003791 Cyclized Derivatives as EG-5 Inhibitors
01/06/2011US20110003784 Opsin-binding ligands, compositions and methods of use
01/06/2011US20110003736 Pesticidal proteins
01/06/2011US20110003735 Peptide derivative fusion inhibitors of hiv infection